BRIEF published on 10/17/2024 at 17:50, 1 month 3 days ago ATEME: Growth in the 3rd quarter of 2024 Growth EMEA Turnover Recurring Income United States/Canada
PRESS RELEASE published on 10/17/2024 at 17:45, 1 month 3 days ago ACTIVITY FOR THE THIRD QUARTER AND THE FIRST NINE MONTHS OF 2024 Ateme's Q3 2024 revenues rise by 10%, US/Canada region grows by 18%. Monthly Recurring Revenue up 18% year-on-year. Benoit Fouchard joins Executive Committee Revenues Executive Committee Growth Q3 2024 ATEME
BRIEF published on 09/30/2024 at 10:05, 1 month 21 days ago Availability of Ateme's 2024 half-year financial report Investors AMF Financial Report Consolidated Accounts ATEME
BRIEF published on 09/26/2024 at 17:50, 1 month 24 days ago Ateme's 2024 half-year results and update of financial objectives Financial Results EBITDA Turnover Véronique Coulmann 2027 Objectives
PRESS RELEASE published on 09/26/2024 at 17:50, 1 month 24 days ago FIRST HALF 2024 RESULTS AND UPDATED GUIDANCE Ateme reports 17% revenue decrease, appoints new CFO, aims for €4M MRR and €22M EBITDA in 2027. Operating costs cut by €1.6M in H1 2024 CFO Appointment Revenue Decrease ATEME 2027 Financial Objectives Operating Costs Reduction
BRIEF published on 07/11/2024 at 17:50, 4 months 9 days ago ATEME: Activity for the 2nd quarter and first half of 2024 Growth EMEA Turnover United States OTT
PRESS RELEASE published on 07/11/2024 at 17:45, 4 months 9 days ago 2ND QUARTER AND 1ST HALF 2024 REVENUES ATEME's Q2 revenues rose by 6% compared to the previous year, while H1 revenues declined by 17%, with EMEA showing strong growth and challenges in the US market. New OTT wins include partnerships with TVRI, Drei TV, and TV+ Revenue EMEA Q2 ATEME OTT
BRIEF published on 06/10/2024 at 20:35, 5 months 10 days ago Appointments to the Ateme management committee Nomination Financial Direction Change ATEME Director Of Operations
PRESS RELEASE published on 06/10/2024 at 20:30, 5 months 10 days ago APPOINTMENTS WITHIN ATEME'S CORPORATE LEADERSHIP Ateme announces CFO Fabrice Sana's departure and appointment of new COO Sébastien Brachet. Company prepares for strategic changes and future growth CFO COO ATEME Fabrice Sana Sébastien Brachet
BRIEF published on 06/04/2024 at 17:50, 5 months 16 days ago ATEME: Situation of Voting Rights and Shares as of May 31, 2024 Voting Rights Euronext Actions ATEME Statuses
Published on 11/21/2024 at 10:03, 56 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 59 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 59 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 24 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 34 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 29 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 54 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 57 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 59 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 59 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 4 hours 1 minute ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 39 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 14 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 14 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
